Clinical trial shows bionic pancreas improves type 1 diabetes management compared to standard insulin delivery method

A device known as a bionic pancreas, which uses next-generation technology to automatically deliver insulin, was more effective at maintaining blood glucose (sugar) levels within normal range than standard-of-care management among people with type 1 diabetes, a new multicenter clinical trial has found. The trial, conducted partly at Nemours Children's Health, Jacksonville, was published in the New England Journal of Medicine.

source https://medicalxpress.com/news/2022-09-clinical-trial-bionic-pancreas-diabetes.html